Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience-Reference-Cited by-同舟云学术

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

Published:2013-08-08 Issue:6 Volume:122 Page:981-987
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Tan Daryl¹,Horning Sandra J.¹,Hoppe Richard T.²,Levy Ronald¹,Rosenberg Saul A.¹,Sigal Bronislava M.³,Warnke Roger A.⁴,Natkunam Yasodha⁴,Han Summer S.³,Yuen Alan¹,Plevritis Sylvia K.³,Advani Ranjana H.¹

Affiliation:

1. Department of Medicine, Oncology Division,

2. Department of Radiation Oncology,

3. Department of Radiology, and

4. Department of Pathology, Stanford University, Stanford, CA

Abstract

Key Points This study is a retrospective analysis of long-term outcomes of patients with FL treated at Stanford University for 4 decades. Study results showed significant improvement in OS in patients with FL despite no change in event-free survival after first-line therapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/6/981/1375576/981.pdf

Reference37 articles.

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project.;Blood,1997

2. The natural history of initially untreated low-grade non-Hodgkin’s lymphomas.;Horning;N Engl J Med,1984

3. Histologic conversion in the non-Hodgkin’s lymphomas.;Acker;J Clin Oncol,1983

4. An autopsy study of histologic progression in non-Hodgkin’s lymphomas. 192 cases from the National Cancer Institute.;Garvin;Cancer,1983

5. Transformation of indolent B-cell lymphomas.;Montoto;J Clin Oncol,2011

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mosunetuzumab for relapsed or refractory follicular lymphoma: a case study;Oncohematology;2024-09-02

2. Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation;Transplantation and Cellular Therapy;2024-09

3. Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis;Blood Advances;2024-08-16

4. Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-08

5. Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies;International Journal of Molecular Sciences;2024-07-15